Few documents feel as intimidating as your own biopsy report — pages of technical language that decide your treatment, written for doctors rather than patients. This plain-English guide explains what a biopsy (pathology) report actually contains, so you can read yours with understanding rather than fear.
What a biopsy report is
A biopsy report is the pathologist’s analysis of the tissue sample taken from you. It is the document that confirms whether cancer is present and, if so, exactly what kind. Almost every cancer treatment decision flows from it, which is why it is worth understanding its main parts.
The key sections, decoded
Diagnosis / impression — the bottom line: the type of cancer (or that no cancer was found).
Tumour type and grade — what the cells are, and how abnormal they look. Grade (low to high) describes how aggressive the cells appear.
Margins — in surgical samples, whether the edges are clear of cancer.
Immunohistochemistry (IHC) — special stains that identify proteins on the cells, helping pin down the type and guide treatment.
Phrases like “well-differentiated” (looks closer to normal) and “poorly differentiated” (more abnormal) describe grade. Uncertain phrases — “favour,” “cannot be excluded” — are a reasonable reason to seek review.
The part that decides modern treatment: biomarkers
Increasingly, the most treatment-relevant lines in a report are the biomarker and molecular results — the findings that molecular oncology and precision medicine are built on. A few concrete examples:
- ER, PR and HER2 in breast cancer — deciding hormonal and HER2-targeted therapy
- EGFR, ALK and PD-L1 in lung cancer — deciding targeted therapy and immunotherapy
- RAS, BRAF and MSI in colorectal cancer
- HER2 and MSI in stomach cancer
- BRCA/HRD in ovarian and pancreatic cancers
If your treatment is being planned and these results are missing where they should apply, that is worth asking about — sometimes via a liquid biopsy or a genetic test, depending on what is needed.
The most valuable question a patient can ask about their own report is not ‘what does this word mean?’ — it is ‘has all the biomarker testing that should be done for my cancer actually been done?’
When to seek a review of your report
Consider a second opinion on the report itself when the diagnosis is described as uncertain, when it is a rare cancer, or when no molecular testing has been done but treatment is being planned. Your preserved tissue block usually allows further testing without a repeat biopsy — our guide on what to send for a second opinion explains how to request it.
Frequently asked questions
What is the most important line in my report?
The diagnosis, followed by the biomarker/molecular results, which increasingly determine treatment.
What does “poorly differentiated” mean?
The cancer cells look very abnormal, which usually indicates a higher grade. It is one factor among several in planning treatment.
Can I get more tests without another biopsy?
Often yes — the preserved tissue block from your original biopsy can be used for additional IHC or molecular testing.
Should I try to interpret it all myself?
Use this guide to understand the structure, but let an oncologist interpret it in your context. You can share it for a specialist review.
Related reading: Molecular Oncology · Precision Medicine · Liquid Biopsy · Cancer Genetic Testing · Second Opinion for Cancer · Cancer Second Opinion: What to Send · Patient Resources
Reviewed by Dr. Harish Kancharla
DM (Medical Oncology), AIIMS, New Delhi · MD (Internal Medicine), PGIMER, Chandigarh
Senior Consultant – Medical Oncology & Hemato-Oncology, Yashoda Hospitals, Somajiguda, Hyderabad
Telangana State Medical Council Registration No. 77186
Last reviewed: August 2026
This article is general information, not personal medical advice. Cancer decisions depend on your individual diagnosis, stage, test results and overall health. Please see our Medical Disclaimer.